Medication info
Telostan Tablet 40/5mg

Telostan Tablet 40/5mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Osco Korea Pharmaceutical Co., Ltd.
Appearance
This is a biconvex oval dual tablet that is white and light gray.
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201605791 · Approved 2016.09.30 · Insurance code 629701230

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components, as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (applicable only to this medicine 40/5 mg). ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients who require careful administration’.) In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
Age 18 years or younger: Administration of this drug is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Osco Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure for patients with essential hypertension where blood pressure is not adequately controlled with either telmisartan or amlodipine alone.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components, as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (applicable only to this medicine 40/5 mg). ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients who require careful administration’.) In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

Age 18 years or younger: Administration of this drug is not recommended because its safety and efficacy have not been established.

Precautions

This medication should not be used by pregnant women, especially during the second and third trimesters, as it can cause serious harm to the fetus. This medication should be avoided in certain patients, such as those with severely impaired liver function, severe hypotension, or heart problems. Additionally, caution is necessary for patients with primary aldosteronism, certain cardiac valve diseases, liver dysfunction, gastrointestinal diseases, and renal artery hypertension when using this medication. Common side effects may include dizziness and peripheral edema; however, rarely fainting or severe allergic reactions may occur, so consult a healthcare provider immediately if symptoms arise. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and alternative treatments should be considered. Hypotension may occur, so particularly patients with low fluid or salt levels should manage their condition carefully before taking the medication and monitor their blood pressure closely during use. There is a risk of increased serum potassium levels; therefore, patients at risk for hyperkalemia should have their potassium levels checked regularly with blood tests. Patients with reduced kidney function may experience further deterioration of kidney function with this medication, so kidney function should be monitored with blood tests periodically. Patients with heart disease should be cautious as this medication may increase the risk of angina or myocardial infarction. Drowsiness or dizziness may occur during medication use, so care should be taken when driving or operating dangerous machinery. This medication may interact with other antihypertensives or certain medications, so it is essential to inform healthcare providers of any other medications being taken. In cases of overdose, symptoms such as hypotension, dizziness, and heart function decline may arise, requiring immediate medical attention. This medication is not recommended for children and adolescents under 18 years of age; dosages should be adjusted carefully for the elderly.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 98 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscular hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • vascular edema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia in males
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is protected from light, at a temperature between 1°C and 30°C. Proper storage will maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

This is a biconvex oval dual tablet that is white and light gray.

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.